Interv Akut Kardiol. 2015;14(1):7-8

Endovaskulární léčba ischemických cévních mozkových příhod

Antonín Krajina1, Dagmar Krajíčková2
1 Radiologická klinika FN, Hradec Králové
2 Neurologická klinika FN, Hradec Králové

Published: April 20, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krajina A, Krajíčková D. Endovaskulární léčba ischemických cévních mozkových příhod. Interv Akut Kardiol. 2015;14(1):7-8.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke. Stroke 2013; (44): 870-947. Go to original source... Go to PubMed...
    2. Péče o pacienty s cerebrovaskulárním onemocněním v České republice. Věstník MZ ČR 2010, částka 2.
    3. Péče o pacienty s akutní cévní mozkovou příhodou. Věstník MZČR 2012, částka 10.
    4. The NINDS t-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; (333): 1581-1587. Go to original source... Go to PubMed...
    5. Riedel CH, Zimmermann P, Jensen-Kondering U, et al. The importance of size. Successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011; 42: 1775-1777. Go to original source... Go to PubMed...
    6. Meunier JM, Wenker E, Lindsell CHJ, Shaw GJ. Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "Nonresponse". Acad Emerg Med 2013; 20(5): 449-455. Go to original source... Go to PubMed...
    7. De los Ríos la Rosa F, Khoury J, Kissela BM, et al. Eligibility for intravenous recombinant tissue-type plasminogen activator within a population. The effect of the European Cooperative Acute Stroke Study (ECASS) III trial. Stroke 2012; 43: 1591-1595. Go to original source... Go to PubMed...
    8. Hausegger KA, Hauser M, Kau T. Mechanical thrombectomy with stent retrievers in acute ischemic stroke. Cardiovasc Intervent Radiol 2014; (37): 863-874. Go to original source... Go to PubMed...
    9. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke. Results of the MERCI trial. Stroke 2005; 36: 1432-1440. Go to original source... Go to PubMed...
    10. Krajina A, Krajíčková D, Lojík M, Chovanec V, Raupach J, Kubíková M et al. Endovaskulární rekanalizace pří léčba akutních uzávěrů mozkových tepen. Ces Slov Neurol N 2010; 73/106(6): 678-684.
    11. Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2014.
    12. Hakimelahi R, Vachta BA, Copen WA, et al. Time and diffusion lesion size in major anterior circulation ischemic strokes. Stroke 2014; (45): 2936-2941. Go to original source... Go to PubMed...
    13. Mordasini P, El-Koussy M, Brekenfeld C, et al. Applicability of tableside flat panel detetor CT parenchymal cerebral blood volume measurement in neurovascular interventions: preliminary clinical experience. Am J Neuroradiol 2012; 33(1): 154-158. Go to original source... Go to PubMed...
    14. Turk AS, Spiotta A, Frei D, et al. Initial clinical experience with the ADAPT technique: A direct aspiration first pass technique for stroke thrombectomy. J Neurointerv Surg 2014; 6(3): 231-237. Go to original source... Go to PubMed...
    15. Power S, Matouk CH, Casaubon LK, et al. Vessel wall magnetic resonance imaging in acute ischemic stroke. Effects of embolism and mechanical thrombectomy on the arterial wall. Stroke 2014; 45: 2330-2334. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.